Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

57
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
57
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

53
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
53
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

89
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
89

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to Robust micelles formulation to improve systemic corticosteroid therapy in sepsis in multiple healthcare systems [Journal of controlled Release, Vol. 381, 10 May 2025, 113635].

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Polyelectrolyte complexation with biofunctionalized multivalent ions: Coarse-grained model and isothermal titration calorimetry experiment.

The Journal of chemical physics·2026
Same author

A Review of Radioactive Strontium for Radiation Protection Purposes.

Health physics·2026
Same author

Selective mRNA Delivery to Activated Macrophages via Hyaluronic Acid-Functionalized Lipid Nanoparticles with Optimized PEGylation.

Biomacromolecules·2026
Same author

Engineered levothyroxine dry powder for inhalation to treat idiopathic pulmonary fibrosis.

Drug delivery and translational research·2026
Same author

Inhibition of TRAP1 in the C-terminal domain influences mitochondria properties and breast cancer cell metabolism.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Related Experiment Video

Updated: Feb 25, 2026

Formulation and Characterization of Bioactive Agent Containing Nanodisks
07:58

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

1.7K

Nanocapsule technology: a review.

Patrick Couvreur1, Gillian Barratt, Elias Fattal

  • 1Université de Paris-Sud, UMR CNRS 8612, Chatenay-Malabry, France. patrick.couvreur@cep.u-psud.fr

Critical Reviews in Therapeutic Drug Carrier Systems
|August 29, 2002
PubMed
Summary
This summary is machine-generated.

Nanocapsules are tiny drug delivery systems with a core and polymer shell. This review covers their manufacturing methods and use in treating diseases like cancer and infections.

More Related Videos

Triplet Fusion Upconversion Nanocapsule Synthesis
08:36

Triplet Fusion Upconversion Nanocapsule Synthesis

Published on: September 7, 2022

3.0K
Microfluidic Fabrication of Core-Shell Microcapsules carrying Human Pluripotent Stem Cell Spheroids
10:51

Microfluidic Fabrication of Core-Shell Microcapsules carrying Human Pluripotent Stem Cell Spheroids

Published on: October 13, 2021

3.8K

Related Experiment Videos

Last Updated: Feb 25, 2026

Formulation and Characterization of Bioactive Agent Containing Nanodisks
07:58

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

1.7K
Triplet Fusion Upconversion Nanocapsule Synthesis
08:36

Triplet Fusion Upconversion Nanocapsule Synthesis

Published on: September 7, 2022

3.0K
Microfluidic Fabrication of Core-Shell Microcapsules carrying Human Pluripotent Stem Cell Spheroids
10:51

Microfluidic Fabrication of Core-Shell Microcapsules carrying Human Pluripotent Stem Cell Spheroids

Published on: October 13, 2021

3.8K

Area of Science:

  • Colloid and Surface Chemistry
  • Materials Science
  • Pharmaceutical Sciences

Background:

  • Nanocapsules are colloidal drug carriers with an oily/aqueous core and polymer membrane.
  • They represent advanced systems for targeted drug delivery.
  • Understanding their fabrication is key to optimizing therapeutic applications.

Purpose of the Study:

  • To provide an extensive review of nanocapsule fabrication technologies.
  • To explore the diverse applications of nanocapsules in disease treatment.
  • To highlight advancements in nanocapsule-based drug delivery.

Main Methods:

  • Review of interfacial polymerization for nanocapsule synthesis.
  • Analysis of interfacial nanodeposition using preformed polymers.
  • Compilation of data on nanocapsule applications in various medical fields.

Main Results:

  • Detailed overview of two primary nanocapsule production methods.
  • Examples of nanocapsule efficacy in treating cancer and infections.
  • Discussion of the potential of nanocapsules as versatile drug carriers.

Conclusions:

  • Nanocapsule technology offers promising routes for drug delivery.
  • Both interfacial polymerization and nanodeposition are viable manufacturing techniques.
  • Nanocapsules show significant potential for treating a range of diseases.